Global Transcriptomic Analysis of Topical Sodium Alginate Protection against Peptic Damage in an In Vitro Model of Treatment-Resistant Gastroesophageal Reflux Disease
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910714 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Pelin Ergun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Hauptthemen laut MEDLINE: Alginates, Gastroesophageal Reflux, Transcriptome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Reckitt Benckiser Healthcare UK Ltd., Slough, UK, Reckitt Benckiser UK.
Abstract (Originalsprache)
Breakthrough symptoms are thought to occur in roughly half of all gastroesophageal reflux disease (GERD) patients despite maximal acid suppression (proton pump inhibitor, PPI) therapy. Topical alginates have recently been shown to enhance mucosal defense against acid-pepsin insult during GERD. We aimed to examine potential alginate protection of transcriptomic changes in a cell culture model of PPI-recalcitrant GERD. Immortalized normal-derived human esophageal epithelial cells underwent pretreatment with commercial alginate-based anti-reflux medications (Gaviscon Advance or Gaviscon Double Action), a matched-viscosity placebo control, or pH 7.4 buffer (sham) alone for 1 min, followed by exposure to pH 6.0 + pepsin or buffer alone for 3 min. RNA sequencing was conducted, and Ingenuity Pathway Analysis was performed with a false discovery rate of ≤0.01 and absolute fold-change of ≥1.3. Pepsin-acid exposure disrupted gene expressions associated with epithelial barrier function, chromatin structure, carcinogenesis, and inflammation. Alginate formulations demonstrated protection by mitigating these changes and promoting extracellular matrix repair, downregulating proto-oncogenes, and enhancing tumor suppressor expression. These data suggest molecular mechanisms by which alginates provide topical protection against injury during weakly acidic reflux and support a potential role for alginates in the prevention of GERD-related carcinogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
- Mellowes Center for Genomic Science and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
- Reckitt Benckiser Healthcare UK Ltd., Slough SL1 3UH, UK.
ORCID-Profile: Pelin Ergun, Tina L Samuels, Angela J Mathison, Kate Plehhova
Förderung
- Reckitt Benckiser Healthcare UK Ltd., Slough, UK
- Reckitt Benckiser UK
Zitieren
APA
Ergun, P., Samuels, T. L., Mathison, A. J., Plehhova, K., Coyle, C., Horvath, L., & Johnston, N. (2024). Global Transcriptomic Analysis of Topical Sodium Alginate Protection against Peptic Damage in an In Vitro Model of Treatment-Resistant Gastroesophageal Reflux Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910714
Vancouver
Ergun P, Samuels TL, Mathison AJ, Plehhova K, Coyle C, Horvath L, et al. Global Transcriptomic Analysis of Topical Sodium Alginate Protection against Peptic Damage in an In Vitro Model of Treatment-Resistant Gastroesophageal Reflux Disease. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910714
BibTeX
@article{Ergun2024,
author = {Ergun, Pelin and Samuels, Tina L and Mathison, Angela J and Plehhova, Kate and Coyle, Cathal and Horvath, Lizzie and Johnston, Nikki},
title = {Global Transcriptomic Analysis of Topical Sodium Alginate Protection against Peptic Damage in an In Vitro Model of Treatment-Resistant Gastroesophageal Reflux Disease},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910714}
}
EUVIMED